Goldman Sachs’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.48B | Sell |
4,219,989
-310,269
| -7% | -$111M | 0.17% | 97 |
|
|
2025
Q4 | $1.48B | Buy |
4,530,258
+83,728
| +2% | +$26.6M | 0.18% | 92 |
|
|
2025
Q3 | $1.25B | Buy |
4,446,530
+215,529
| +5% | +$62.5M | 0.15% | 114 |
|
|
2025
Q2 | $1.18B | Sell |
4,231,001
-174,963
| -4% | -$49.6M | 0.16% | 110 |
|
|
2025
Q1 | $1.37B | Buy |
4,405,964
+161,306
| +4% | +$47.6M | 0.22% | 71 |
|
|
2024
Q4 | $1.11B | Sell |
4,244,658
-760,485
| -15% | -$226M | 0.17% | 94 |
|
|
2024
Q3 | $1.61B | Sell |
5,005,143
-176,487
| -3% | -$57.7M | 0.26% | 65 |
|
|
2024
Q2 | $1.62B | Buy |
5,181,630
+876,921
| +20% | +$258M | 0.27% | 58 |
|
|
2024
Q1 | $1.22B | Buy |
4,304,709
+451,809
| +12% | +$132M | 0.22% | 76 |
|
|
2023
Q4 | $1.11B | Buy |
3,852,900
+286,452
| +8% | +$78M | 0.2% | 83 |
|
|
2023
Q3 | $959M | Buy |
3,566,448
+675,328
| +23% | +$169M | 0.2% | 88 |
|
|
2023
Q2 | $642M | Buy |
2,891,120
+196,332
| +7% | +$45.6M | 0.14% | 133 |
|
|
2023
Q1 | $651M | Buy |
2,694,788
+23,835
| +0.9% | +$5.85M | 0.15% | 119 |
|
|
2022
Q4 | $701M | Sell |
2,670,953
-6,266,036
| -70% | -$1.68B | 0.17% | 101 |
|
|
2022
Q3 | $2.01B | Buy |
8,936,989
+1,912,446
| +27% | +$464M | 0.51% | 23 |
|
|
2022
Q2 | $1.71B | Buy |
7,024,543
+4,462,166
| +174% | +$1.09B | 0.43% | 32 |
|
|
2022
Q1 | $620M | Sell |
2,562,377
-1,035,106
| -29% | -$238M | 0.13% | 131 |
|
|
2021
Q4 | $809M | Buy |
3,597,483
+510,832
| +17% | +$108M | 0.16% | 102 |
|
|
2021
Q3 | $656M | Buy |
3,086,651
+397,889
| +15% | +$91.6M | 0.14% | 127 |
|
|
2021
Q2 | $655M | Buy |
2,688,762
+527,794
| +24% | +$130M | 0.15% | 120 |
|
|
2021
Q1 | $538M | Buy |
2,160,968
+10,366
| +0.5% | +$2.47M | 0.14% | 138 |
|
|
2020
Q4 | $494M | Buy |
2,150,602
+53,029
| +3% | +$12.2M | 0.13% | 138 |
|
|
2020
Q3 | $533M | Sell |
2,097,573
-824,080
| -28% | -$204M | 0.15% | 116 |
|
|
2020
Q2 | $689M | Sell |
2,921,653
-322,244
| -10% | -$73.5M | 0.21% | 77 |
|
|
2020
Q1 | $658M | Sell |
3,243,897
-1,363,214
| -30% | -$298M | 0.23% | 81 |
|
|
2019
Q4 | $1.11B | Buy |
4,607,111
+476,999
| +12% | +$105M | 0.28% | 59 |
|
|
2019
Q3 | $799M | Sell |
4,130,112
-209,592
| -5% | -$40.2M | 0.23% | 74 |
|
|
2019
Q2 | $800M | Sell |
4,339,704
-528,862
| -11% | -$94.7M | 0.23% | 71 |
|
|
2019
Q1 | $925M | Sell |
4,868,566
-636,369
| -12% | -$122M | 0.28% | 54 |
|
|
2018
Q4 | $1.07B | Sell |
5,504,935
-9,862
| -0.2% | -$1.92M | 0.34% | 42 |
|
|
2018
Q3 | $1.14B | Sell |
5,514,797
-185,094
| -3% | -$36.5M | 0.3% | 46 |
|
|
2018
Q2 | $1.05B | Sell |
5,699,891
-1,414,753
| -20% | -$250M | 0.28% | 47 |
|
|
2018
Q1 | $1.21B | Sell |
7,114,644
-521,661
| -7% | -$95.8M | 0.31% | 40 |
|
|
2017
Q4 | $1.33B | Buy |
7,636,305
+746,205
| +11% | +$132M | 0.32% | 37 |
|
|
2017
Q3 | $1.28B | Buy |
6,890,100
+994,665
| +17% | +$176M | 0.31% | 31 |
|
|
2017
Q2 | $1.02B | Buy |
5,895,435
+878,532
| +18% | +$143M | 0.26% | 48 |
|
|
2017
Q1 | $823M | Buy |
5,016,903
+984,265
| +24% | +$164M | 0.22% | 65 |
|
|
2016
Q4 | $590M | Buy |
4,032,638
+1,051,691
| +35% | +$158M | 0.17% | 90 |
|
|
2016
Q3 | $497M | Sell |
2,980,947
-431,362
| -13% | -$72.9M | 0.15% | 99 |
|
|
2016
Q2 | $519M | Buy |
3,412,309
+9,431
| +0.3% | +$1.47M | 0.17% | 86 |
|
|
2016
Q1 | $510M | Buy |
3,402,878
+505,893
| +17% | +$75.2M | 0.17% | 97 |
|
|
2015
Q4 | $470M | Sell |
2,896,985
-272,495
| -9% | -$42.8M | 0.15% | 126 |
|
|
2015
Q3 | $438M | Sell |
3,169,480
-190,569
| -6% | -$30M | 0.15% | 115 |
|
|
2015
Q2 | $516M | Buy |
3,360,049
+117,208
| +4% | +$18.8M | 0.16% | 111 |
|
|
2015
Q1 | $518M | Buy |
3,242,841
+120,728
| +4% | +$19M | 0.17% | 108 |
|
|
2014
Q4 | $497M | Sell |
3,122,113
-3,104,397
| -50% | -$484M | 0.16% | 107 |
|
|
2014
Q3 | $875M | Buy |
6,226,510
+2,722,219
| +78% | +$355M | 0.28% | 46 |
|
|
2014
Q2 | $415M | Buy |
3,504,291
+466,826
| +15% | +$54M | 0.13% | 145 |
|
|
2014
Q1 | $375M | Sell |
3,037,465
-421,965
| -12% | -$51.2M | 0.12% | 157 |
|
|
2013
Q4 | $395M | Buy |
3,459,430
+611,026
| +21% | +$69.5M | 0.13% | 148 |
|
|
2013
Q3 | $319M | Sell |
2,848,404
-73,836
| -3% | -$8.01M | 0.12% | 167 |
|
|
2013
Q2 | $288M | Buy |
+2,922,240
| New | +$303M | 0.11% | 171 |
|
Other funds holding AMGN
VCM
VPM
Goldman Sachs's AMGN Position: Q1 2026 in Review
Goldman Sachs reduced its Amgen (AMGN) stake by 6.8% in Q1 2026, selling an estimated $111M and leaving 4,219,989 shares worth $1.48B. The position accounts for 0.17% of the portfolio, ranked #97.
Goldman Sachs first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.01B in Q3 2022. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Goldman Sachs held 4,219,989 shares of Amgen worth $1.48B as of Q1 2026.
- Goldman Sachs sold 310,269 Amgen shares in Q1 2026, an estimated $111M.
- Amgen made up 0.17% of Goldman Sachs's portfolio in Q1 2026, its #97 holding.
- Goldman Sachs first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Amgen position peaked at $2.01B in Q3 2022.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.